Standing Stone, Inc. Adds Inpatient Anticoagulation Management Capabilities to CoagClinic to Support the Joint Commission National Patient Safety Guidelines and Compliance Reporting

WESTPORT, Conn.--(Business Wire)--
Standing Stone, Inc., an industry leader in disease management applications, is
pleased to announce the addition of inpatient anticoagulation facilities to its
hallmark product: CoagClinic. Unfractionated heparin administration has been
added to the warfarin and low molecular weight heparin management facilities to
provide a single anticoagulation solution for all inpatient and outpatient
needs. Clinicians can now manage, track and analyze warfarin, low molecular
weight heparin and unfractionated heparin patient populations from a single,
easy-to-use, web-based application. Enhancing CoagClinic to provide
comprehensive inpatient anticoagulation management further underscores Standing
Stone`s leadership in the marketplace.

Systematic anticoagulation management in the outpatient arena has consistently
shown to reduce the risk of adverse events associated with anticoagulation
therapy and increase the overall quality of patient care. In 2008, the Joint
Commission extended the National Patient Safety Guidelines around
anticoagulation to include inpatient populations. CoagClinic helps hospitals
support inpatient and outpatient anticoagulation populations.

"Standing Stone responded quickly to the challenge of extending CoagClinic to
accommodate the requirements of inpatient anticoagulation," said Mark W.
Wurster, MD FACP, Standing Stone`s Chief Medical Officer and Clinical Assistant
Professor of Internal Medicine at Ohio State University. "They worked closely
with their customers and consulting medical staff to develop the tools required
for inpatient anticoagulation administration."

"We have a very large and satisfied customer base. They know that they can rely
on us to respond to changes in the marketplace which impact anticoagulation
management" said Albert J. Bartosic, President of Standing Stone Inc. "In this
case, some facilities have indicated a need for comprehensive
inpatient-to-outpatient anticoagulation management software; others simply need
an inpatient population reporting and analysis system so they can easily
aggregate data for NPSG compliance requirements. We have provided a
cost-effective solution across this spectrum of needs."

About Standing Stone Inc.

Standing Stone Inc. (SSI) is a privately-held disease state management company
dedicated to enhancing the quality of care provided to patients who require
long-term therapy for chronic disease management. The Company`s web-based
applications, which provide specialized decision support to health care
professionals throughout the country, are market leaders. SSI also collaborates
with other manufactures to deliver seamless value-added solutions to its
customers.

For more information on SSI, please visit www.standingstoneinc.com.

Standing Stone, Inc.
Barbara Chopin, 203-226-6784
bchopin@standinsgstoneinc.com

Copyright Business Wire 2009